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S everal studies support a link between energy metabolism and bone [1 , 2].  Osteocalcin (OC) is 
produced by osteoblastic cells as a marker of bone for-
mation,  and it additionally appears to be involved in fat 
and glucose metabolism [3].
Lee et al.  reported that knockout mice with both OC 
alleles eliminated exhibited expanded fat mass,  dimin-
ished insulin secretion,  and β-cell proliferation [4].  On 
the other hand,  when OC levels were higher,  fat pads 
were small,  β-cell proliferation was higher,  and the mice 
showed higher insulin sensitivity.  When recombinant 
uncarboxylated OC was administered to wild-type mice,  
increased adiponectin expression,  reduction of fat mass,  
better handling of glucose,  and decreased weight gain in 
the presence of a high-fat diet were observed [5].
Emerging evidence from human studies has shown 
that OC regulates glucose metabolism and fat mass [6-11].  
OC has been shown to have an inverse association with 
fat mass [7 , 8],  percentage body fat [6-8 , 10],  and waist 
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Osteocalcin (OC) is inversely related to body fat distribution and fasting glucose levels.  We sought to observe 
the effect of OC on fat distribution and subclinical atherosclerosis as measured by carotid intima-media thick-
ness (CIMT) in premenopausal obese women.  In this prospective observational study,  totally,  73 premeno-
pausal obese women (aged 17-55 years) and 53 healthy women (aged 20-50 years) with normal weight were 
included as controls.  Anthropometric measurements,  total fat and fat ratio,  insulin,  fasting blood glucose,  
and OC levels were estimated.  Ultrasonography was used to assess fat distribution,  and fat thickness was mea-
sured in 4 regions.  Subcutaneous fat (SCF),  visceral fat (VF),  and preperitoneal fat (PPF) thicknesses were 
considerably higher in obese subjects (p< 0.01) than healthy controls,  while OC levels were significantly lower.  
No correlation was observed between OC levels and SCF,  VF,  or PPF.  In a multiple regression analysis,  OC was 
significantly positively associated with SCF (p= 0.04,  Beta = 0.284).  No associations were observed between OC 
levels and VF,  PPF,  or CIMT.  A significant association was observed between parathyroid hormone (PTH) and 
VF (p= 0.021,  Beta = 0.284),  and vitamin D levels were inversely associated with VF (p= 0.002,  r = −0.366).  OC 
levels were lower in premenopausal obese women than normal-weight healthy controls,  but OC exhibited no 
correlation with VF or PPF,  and only a weak positive association with SCF.  Additionally,  VF was positively 
correlated with PTH and inversely correlated with vitamin D.  These results suggest that OC may be an early 
indicator of lipid accumulation in te subcutaneous area and development of atherosclerosis.
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circumference (WC) in men [9].  On the other hand,  
regional variations in OC production in fat tissue are 
still unresolved,  and there are only a few studies that 
have reported OC levels in premenopausal women.
Although recent studies have proposed an associa-
tion between serum OC and cardiovascular events,  the 
findings are contradictory.  Particular uncertainty remains 
regarding the independent association between OC and 
atherosclerosis.  Pennisi et al.  showed that patients with 
severe atherosclerotic lesions of the carotid and/or fem-
oral artery had lower OC levels [12].  Kanazawa et al.  
stated that OC levels correlated inversely with carotid 
intima-media thickness (CIMT) in men [6].  Serum OC 
levels were also linked to lower risks of coronary heart 
disease and metabolic disorders in Chinese adults [13,14].  
Finally,  serum OC levels have been shown to be inde-
pendently and inversely related to carotid atherosclero-
sis in type 2 diabetics [15].  It is possible that the effects 
of confounding factors were responsible for these vary-
ing results.
In the present study,  therefore,  we examined the 
potential correlation between serum OC levels and each 
of body fat composition and CIMT in premenopausal 
obese women.
Methods
Study population. In this prospective observa-
tional study,  totally,  73 obese premenopausal women 
(aged 17-55 years) and 53 healthy women (aged 20-50  
years) with normal weight were included in this pro-
spective observational study.  Patients with any of the 
following were excluded: irregular menstrual cycle,  a 
diagnosis of polycystic ovary syndrome,  physical exer-
cise more than 2 h per week,  currently breastfeeding,  
pregnant,  use of any drug that could affect glucose 
metabolism or body composition,  underlying disorders 
of glucose or lipid metabolism,  and a current smoking 
habit.  Both oral and written consents were obtained 
from all participants.  Our study was approved by the 
Local Medical Ethics Committee of Pamukkale 
University (application number: 60116787-020/41760).
Anthropometric evaluation. Subjects were con-
sidered to be obese if their body mass index (BMI) was 
> 30 kg/m2.  BMI was calculated as weight (kg) divided 
by height (m)2.  WC was measured midway between the 
lowest rib and the iliac crest while the participants were 
standing upright.  Bioelectrical impedance analysis 
(BIA) was used to estimate total fat mass,  and percent-
age body fat and fat mass of the trunk body (kg) were 
determined using TANITA BC-418 (Tanita Corp.,  
Tokyo).
Ultrasound examination. All sonographic mea-
surements were performed by a single radiologist with 
15 years of experience in conventional ultrasonography 
(US).  Subcutaneous fat (SCF) and preperitoneal fat 
(PPF) thickness measurements were done using a 5-12  
MHz linear transducer,  and visceral fat (VF) thickness 
measurements were done using a 3-5 MHz convex array 
transducer with a Logic E9 ultrasound machine (GE 
Healthcare,  Milwaukee,  WI,  USA).
Abdominal fat measurements. All the abdominal 
fat measurements were obtained with the subject in the 
supine position by placing the probe perpendicular to 
the skin surface of the upper abdomen.  Scanning was 
performed longitudinally from the xiphoid process to 
the umbilicus along the midline,  and measurements 
were obtained from the image captured when the probe 
touched the skin surface lightly without applying pres-
sure.  SCF was defined as the minimum distance from 
the cutaneous boundary to the linea alba,  while PPF 
was defined as the maximum distance between the linea 
alba and the surface of the left lobe of the liver.  VF 
thickness was measured as the distance between the 
linea alba and the anterior aspect of the vertebral body.  
The measurement of VF thickness was obtained 1 cm 
above the umbilicus on the imaginary line drawn 
between the xiphoid process and the umbilicus.  All 
measurements were repeated 4 times,  and the averages 
of these 4 measurements were used as the final values of 
the SCF,  PPF,  and VF thicknesses.
CIMT measurements. CIMT measurements were 
performed with a 5-12 MHz linear transducer using the 
same US machine with the patient lying in a supine 
position with a small cushion placed under the shoul-
ders to aid extension of the neck during neck rotateion 
to the side opposite to the common carotid artery 
(CCA) being measured.  The CCAs on both sides were 
depicted in the longitudinal plane,  and measurements 
were obtained from the far wall of the CCA 2 cm prox-
imal to the carotid bulb.  Three measurements were 
performed on both CCAs using the automatic inti-
ma-media thickness measurement program of the 
ultrasound system.  The average of these three measure-
ments was recorded as the final value.
Biochemical analyses. For biochemical analyses,  
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blood samples were taken after a period of overnight 
fasting.  The levels of serum total cholesterol,  high den-
sity lipoprotein (HDL) cholesterol,  triglyceride,  and 
fasting glucose were measured.  Fasting insulin levels 
were measured by chemiluminescent immunoassays.  
The insulin resistance (IR) homeostasis model assess-
ment (HOMA-IR) index was calculated using the for-
mula: (fasting plasma glucose (mmol/L) x fasting 
plasma insulin (mIU/L))/22.5 [16].  A cut-off value of 
2.7 was accepted to determine a state of IR.  Serum 
25-hydroxyvitamin vitamin D (25[OH]D) levels were 
measured by high performance liquid chromatography,  
serum parathyroid hormone (PTH) levels by electro-
chemiluminescence immunoassay,  and serum OC lev-
els by chemiluminescence immunoassay.
Statistical analyses. For the statistical analysis,  
SPSS v.18.0 for Windows (SPSS,  Chicago,  IL,  USA) 
was used.  Continuous and categorical data are shown as 
means ± standard deviations and as percentages,  
respectively.  When parametric test assumptions were 
provided,  an independent sample t test was used for 
intergroup comparisons.  If assumptions were not pro-
vided,  the Mann Whitney U test was used.  Correlation 
between continuous variables was analyzed using the 
Spearman correlation coefficient.  Multiple linear 
regression analysis was used to identify the factors asso-
ciated with OC.  A level of p < 0.05 was accepted as sta-
tistically significant.
Results
The anthropometric measurements of the subjects 
are shown in Table 1.  Obese subjects had an increased 
WC,  body fat mass,  BMI indicating adiposity,  and 
higher VF,  PPF,  and SCF compared to normal control 
subjects (p < 0.01).  The biochemical and hormonal vari-
ables of obese subjects and controls are shown in Table 
2.  US measurements and evaluations of subjects are 
shown in Fig. 1.
The OC concentration was 18.26 ng/mL for obese 
subjects and 22.53 ng/mL for the controls,  and the dif-
ference was statistically significant.  While the 25(OH)D 
levels and calcium levels were similar,  PTH levels were 
higher in obese subjects (61.94 pg/mL for obese subjects 
and 52.51 pg/mL for controls (p = 0.049)).  We divided 
the obese groups into two subgroups based on 
HOMA-IR,  and patients with IR had PTH,  OC,  and 
25(OH)D levels comparable to those of patients without 
IR.
OC was positively correlated with PTH (p = 0.007,  
r = + 0.315).  There were no significant correlations 
between OC and other biochemical and hormonal 
parameters,  including 25(OH)D.  OC showed no cor-
relation with WC,  BMI,  body fat mass,  VF,  or PPF.  
However,  OC showed a weak positive correlation with 
SCF (p = 0.035,  r = 0.258) in obese patients but no cor-
relation with SCF in the controls (p = 0.424,  r = −0.127).  
It also showed no correlation with CIMT.
Inverse correlations were observed between CIMT 
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Table 1　 Antropometric measures and fat distrubution of obese and controls
OBESE (n=73) CONTROL (n=53)
Mean±S.D Med (min-max) Mean±S.D Med (min-max) P
Age 35±6 37 (17-52) 32.±8 38 (18-55) >0.05
Weight (kg) 97.26±15.75 93.8 (69.1-134.0) 61.03±10.27 59.1 (42.4-90.7) <0.001＊α
BMI (kg /m2) 38.32±5.38 37.7 (30.3-50.4) 23.46±3.46 22.7 (16.7-30.4) <0.001＊β
WC (cm) 107.38±11.27 107 (80-131) 80.02±9.95 79.5 (64-107) <0.001＊α
Trunckal fat percent 38.73±5.06 39. (23.5-49.4) 20.41±8.72 22.4 (3.-38.8) <0.001＊α
Total fat mass (kg) 42.9±10.51 42.5 (22.8-68.5) 16.74±6.82 16.4 (5.1-35.2) <0.001＊α
Percent body fat 43.54±4.15 44.4 (32.2-51.6) 26.5±7.07 27.8 (10.6-40.4) <0.001＊β
VF (mm) 54.18±22.32 52. (17-149) 30.05±11.55 29 (9.3-57.8) <0.001＊β
PPF (mm) 20.37±30.47 11 (7.3-18.8) 6.73±3.06 6 (2-14.4) <0.001＊β
SCF (mm) 34.39±10.52 33 (3.8-60) 18.59±8.55 18.05 (3-39) <0.001＊α
CIMT (mm) 1.38±1.97 0.7 (0.46-3.35) 0.54±0.09 0.54 (0.4-0.71) <0.001＊β
＊p<0.05 statistically significant; S.D,  Standart Deviation; Med,  Median;  BMI,  Body mass index; WC,  Waist circumference; VF,  
Visseral fat; PPF,  Preperitoneal fat; SCF,  Subcutanous fat; CIMT,  Carotis intima media thickness; α,  Independent Samples t test; β,  
Mann Whitney U test
and each of the following: vitamin D levels in obese 
patients (p = 0.028,  r = −0.269),  VF (p = 0.002,  
r = −0.366),  and WC (p = 0.025,  r = −0.263).  However,  
PTH showed positive correlations with CIMT 
(p = 0.018,  r = + 0.291) and WC (p = 0.042,  r = + 0.241).
There were no associations between OC and VF,  
PPF,  or CIMT.  A significant association was detected 
between PTH and VF (p = 0.021,  Beta = 0.284).  The 
levels of 25(OH)D were inversely related to VF (p = 0.05,  
Beta = −0.236).  In multiple regression analysis (Table 3),  
OC was significantly positively associated with SCF 
(p = 0.04,  Beta = 0.284).
Discussion
We assessed OC levels in 73 obese premenopausal 
and 53 healthy women in this prospective observational 
study.  The results revealed that OC levels were lower in 
premenopausal obese women than in healthy controls 
and that OC was positively associated with SCF.  In pre-
menopausal obese women,  we observed that circulat-
ing serum OC was not associated with blood glucose 
levels,  IR,  WC,  BMI,  VF,  or PPF.  These findings are 
consistent with recent studies showing that bone and 
adipose tissue exert reciprocal regulation.
Little is known about body fat composition and 
serum OC levels in obese individuals.  A previous 
report found an association between BMI and serum 
OC.  BMI appears to be inversely correlated with serum 
OC in elderly people [7],  postmenopausal women 
[17 , 18],  and premenopausal women [19].  When post-
menopausal women without metabolic syndrome were 
examined,  no relationship was observed between BMI 
and bone mineral density.  However,  OC showed a pos-
itive correlation with waist and hip circumference.  This 
suggests that there might be a positive correlation 
between adipose tissue and bone formation in patients 
who do not have IR [20].  Some studies have reported 
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Table 2　 Biochemical and hormonal variables of obese and controls
OBESE (n=73) CONTROL (n=53)
Mean±S.D Med (min-max) Mean±S.D Med (min-max) P
FBG (mg/dL) 96.36±10.83 95 (74-132) 89.69±7.62 88 (79-116) <0.001＊α
Insulin (uIU/mL) 19.06±10.42 16 (3.7-53) 9.13±4.25 7.95 (3.68-25) <0.001＊β
HOMA 4.55±2.79 3.7 (0.8-16.61) 1.98±0.93 1.79 (0.83-5.44) <0.001＊β
Creatinine (mg/dL) 0.65±0.11 0.64 (0.47-1.02) 0.64±0.1 0.63 (0.41-0.92) 0.718β
ALT (IU/L) 20.15±11.12 17 (8-73) 16.04±10.09 13 (5-62) 0.001＊β
LDL (mg/dL) 106.29±27.21 107 (53-178) 93.33±29.38 88 (40-166) 0.013＊α
HDL (mg/dL) 50.45±11.2 51 (31-94) 66.49±14.28 64 (43-102) <0.001＊α
TG (mg/dL) 116.32±54.83 104 (35-309) 85.18±45.01 74 (36-295) <0.001＊β
TSH (uIU/mL) 3.05±5.70 2.23 (0.12-50) 1.98±1.16 1.55 (0.29-5.37) 0.020＊β
Calcium (mg/dL) 9.11±0.44 9.17 (7.78-10.26) 9.09±0.42 9.05 (8.21-10.5) 0.385β
PTH (pg/mL) 61.94±24.68 57 (16-130) 52.5±17.7 50.5 (23-119) 0.049＊β
Vitamin D (ng/mL) 13.39±9.95 11 (3-50) 13.99±15.51 10 (3-94) 0.433β
Phosphorus (mg/dL) 3.21±0.55 3.26 (2.02-4.39) 3.34±0.45 3.46 (2.51-4.28) 0.17β
Magnesium (mg/dL) 1.91±0.15 1.92 (1.5-2.38) 1.94±0.18 2 (1.5-2.25) 0.022＊β
ALP (IU/L) 77.15±25.22 76 (36-221) 55.35±16.18 53 (10-98) <0.001＊β
Osteocalcin (ng/mL) 18.2±5.27 18 (7.52-35) 22.53±6.84 22 (11.93-40) <0.001＊α
＊p<0.05 statistically significant; S.D,  Standard Deviation; Med,  Median; FBG,  Fasting blood glucose; ALT,  Alanine transaminase;  
LDL,  Low density lipoprotein; HDL,  High density lipoprotein; TG,  Triglyceride; TSH,  Thyroid stimulating hormone; PTH,  Parathyroid 
hormone; ALP,  Alkaline phosphatase; α,  Independent Samplest test; β,  Mann Whitney U test
Fig. 1　 Ultrasonographical measurement and evaluation of sub-
jects.
that there is no association between BMI and OC levels 
in postmenopausal women [21];  although the results 
of studies suggested that an association between BMI 
and OC might exist in obese individuals,  but not in 
non-obese subjects [18].  A recent metaanalysis found 
that there was an inverse correlation between OC levels 
and BMI,  but there was heterogeneity among the cor-
relation coefficients across studies.  A subgroup analysis 
revealed that this heterogeneity was mostly attributable 
to the inclusion of studies in which the subjects had 
metabolic syndrome [22].
These differing results may have been caused by a 
deficiency in the measurements of fat mass,  or may 
have been related to inherent differences in the study 
populations.  In addition,  the relationship between 
bone and adipose tissue metabolism may vary in the 
pre- and postmenopausal periods.  In our present study,  
we did not find any association between BMI and OC 
levels in premenopausal obese women.  Measurement of 
the fat distribution rather than BMI may therefore be 
more informative regarding the relationship between 
energy and bone metabolism.
Kanazawa et al.  stated that serum uncarboxylated OC 
and total OC were linked to body fat in type 2 diabetic 
men [11].  Pittas et al.  also found that,  after multivariate 
adjustments,  the OC concentration remained inversely 
associated with markers of adiposity,  BMI,  body fat,  
and percentage of body fat in adults aged 65 years and 
older (mean age 71 years,  BMI 26.9 kg/m2,  5% with 
diabetes) [7].  Despite these studies showing a relation-
ship between fat distribution and OC,  similar studies in 
obese people without underlying comorbidities are lim-
ited.
In our study,  we found that OC showed a positive 
association with SCF,  although we could not find any 
correlation between OC and VF,  PPF in obese pre-
menopausal women without diabetes.  In contrast to our 
study,  Kim et al.  found an inverse correlation between 
OC and visceral obesity in Korean overweight and obese 
men.  They also found that there was no association 
between OC and the SF area (SFA) [23].  In their study,  
Kim et al.  used computed tomography (CT) to measure 
the VF area (VFA),  and SFA was calculated by sub-
tracting the VFA from the total abdominal fat area.  In 
our study,  we used US to directly measure SCF instead 
of calculating it from the VFA.  Similar to our study,  the 
study population in the report of Kim et al.  also 
included only obese and overweight people and did not 
include diabetics.  Whereas they measured OC in male 
subjects,  we measured OC in premenopausal obese 
women,  and this may be one of the reasons for our con-
flicting results.  Other potential contributing factors to 
the differences in our results could be variations in the 
selection criteria and in the demographic characteristics 
of the populations examined,  including race/ethnicity.  
In another recent study,  VFA was assessed by magnetic 
resonance imaging in middle-aged and elderly commu-
nity-living subjects,  and their results also demonstrated 
that serum OC levels showed an inverse correlation 
with visceral obesity [24].
Serum OC levels were also found to be significantly 
inversely correlated with,  and to be significantly pre-
dictive of,  fat and trunk fat in older Swedish men [8].  
For both diabetic and nondiabetic subjects,  plasma OC 
showed strong inverse correlations to BMI and fat mass,  
but it was not correlated to height or lean mass in this 
study.  Total lean mass,  total fat mass,  percent body fat,  
and the fat mass of the trunk were assessed using 
dual-emission X-ray absorptiometry [8].  We also mea-
sured total fat mass,  percentage body fat,  and truncal 
fat mass by BIA.  The serum OC level did not show any 
association with any of the above measurements.  In a 
related study conducted in a Chinese population,  
serum OC was associated with HDL cholesterol and 
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Table 3　 Multivariate association between serum osteocalcin and adiposity indices in obese patients
Standardized Coefficients 
Beta Sig.
95% Confidence Interval for B
Lower Bound Upper Bound
Truncal Fat Percent  0.144 0.30 -0.139 0.439
WC -0.313 0.06 -0.295 0.007
VF  0.134 0.37 -0.039 0.103
PPF -0.113 0.37 -0.063 0.024
SCF  0.284 0.04＊  0.004 0.282
＊p<0.05 statistically significant; WC,  Waist circumference; VF,  Visceral fat; PPF,  Preperitoneal fat; SCF,  Subcutaneous fat
percentage body fat in males,  whereas serum OC levels 
in premenopausal women were associated with tri-
glyceride levels [10].  In postmenopausal women,  an 
inverse relationship was found between OC and 
abdominal obesity parameters;  uncarboxylated OC 
levels also correlated inversely with the waist-hip ratio,  
VFA,  and fat mass [25].
Studies have shown inconsistent findings regarding 
the relationship between serum OC levels and athero-
sclerosis [26 , 27].  This might be due to differences in 
the study populations or to various confounding factors 
that are associated with serum OC levels.  Serum OC 
levels showed a significant inverse correlation with 
CIMT (r = −0.107,  p < 0.01) in Chinese postmenopausal 
women [27].  The Shanghai Changfeng Study looked at 
the correlation between OC levels and carotid athero-
sclerosis in Chinese middle-aged and elderly adult 
males and at the correlation of OC with carotid athero-
sclerosis in the euglycemic subgroup.  Men with OC 
levels in the fourth quartile had a 0.57-fold reduced risk 
of carotid plaques compared to those in the lowest 
quartile after adjustment for traditional cardiovascular 
disease risk factors.  These findings suggest that OC is 
independently associated with carotid atherosclerosis in 
euglycemic males and that OC may play a role not only 
in glucose metabolism but also in the development of 
atherosclerosis [28].  In our study,  CIMT did not cor-
relate with OC but correlated with PTH and vitamin D,  
probably due to the fact that subclinical atherosclerosis 
might not yet have developed in this age group.  
Additionally,  even if VF measurements were increased,  
suggesting an increased risk of cardiovascular mortality,  
we found that VF showed an inverse correlation with 
25(OH) vitD but not with OC levels.  This suggests that,  
in the premenopausal period,  low vitamin D levels may 
be a better indicator of increased cardiovascular risk 
than low OC levels.  Gilardini et al.  observed that PTH 
levels were higher in obese subjects with carotid calcifi-
cations than in those without calcifications [29].  
Increased PTH levels in obese patients are believed to be 
due to the increased concentrations of vitamin D in 
adipose tissue [30].
Alkaline phosphatase (ALP) is a ubiquitous enzyme 
present in all tissues but mainly concentrated in the 
liver,  kidney,  and bone [31].  In this study,  ALP levels 
were significantly higher in obese patients compared to 
healthy controls.  This may be a result of underlying 
liver damage due to obesity.  OC levels are closely 
related to bone metabolism,  and numerous studies have 
supported this relationship.  The findings of our study 
also suggest that OC has a positive association with SCF.  
Additionally,  VF showed a positive correlation with 
PTH and an inverse correlation with vitamin D levels.  
We excluded patients with impaired lipid or glucose 
metabolism from our study,  but we did observe a statis-
tically significant association between obesity and 
CIMT.  Our results suggest that OC may be an early 
indicator of diseases associated with obesity and bone 
metabolism.  Further studies are needed to shed more 
light on this subject.
Study limitations. This study had several limita-
tions.  First,  we measured total OC rather than uncar-
boxylated OC.  However,  Kanazawa et al.  stated that 
levels of serum uncarboxylated OC as well as total OC 
were related to body fat in men with type 2 diabetes 
[12].  Secondly,  we measured fat distribution using US 
and BIA,  although CT might have been a better tool.  A 
third possible limitation of our study was that sex hor-
mone levels and some liver function parameters,  e.g 
AST or γ-GTP of the subjects were not measured.
On the other hand,  measuring SCF directly instead 
of calculating it from VF measurements is a definite 
strength of our study,  as is the evaluation of body fat 
distribution using 2 different methods.  Since we 
included only obese premenopausal women without any 
underlying comorbidities,  our results may be more rep-
resentative of the relationship between bone and adi-
pose tissue.
Inconclusion. The study results indicated that OC 
levels were lower in premenopausal obese women com-
pared to healthy controls,  but no correlation was 
observed between OC levels and VF or PPF.  However,  
there was a positive correlation between OC and SCF.  
Additionally,  VF showed a positive correlation with 
PTH and an inverse correlation with vitamin D.  The 
current study showed that serum OC levels are signifi-
cantly associated with obesity.  This observation sug-
gests that bone might not merely be an endocrine target,  
but may also have an effect on obesity,  and that OC 
levels may be an early indicator of lipid accumulation in 
the subcutaneous area and of the development of ath-
erosclerosis.
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